Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16191510rdf:typepubmed:Citationlld:pubmed
pubmed-article:16191510lifeskim:mentionsumls-concept:C0024419lld:lifeskim
pubmed-article:16191510lifeskim:mentionsumls-concept:C2700641lld:lifeskim
pubmed-article:16191510lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:16191510lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:16191510pubmed:issue3lld:pubmed
pubmed-article:16191510pubmed:dateCreated2005-9-29lld:pubmed
pubmed-article:16191510pubmed:abstractTextWe retrospectively reviewed the immunophenotypic profile of 75 cases of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) analyzed by flow cytometry. All patients had monoclonal IgM (median, 2,100 mg/dL [21 g/L]) in serum and were considered clinically to have WM. The neoplastic cells, in all cases, expressed monoclonal immunoglobulin light chain (k, 55; l, 20) and CD19, and every case assessed was positive for CD20 (n=68) and CD52 (n=60). The results for other antigens assessed in decreasing frequency of positivity were as follows: surface IgM (26/28 [93%]), CD79b (11/13 [85%]), CD11c (13/16 [81%]), CD25 (5/7 [71%]), CD23 (17/28 [61%]), CD38 (24/50 [48%]), FMC7 (11/29 [38%]), CD22 (4/12 [33%]), CD5 (3/65 [5%]), and CD10 (1/38 [3%]). These results show that the immunophenotype of LPL/WM is variable and overlaps with other B-cell lymphoproliferative disorders. CD23, usually of dim intensity, and CD11c are expressed commonly in LPL/WM. Rare CD5+ and CD10+ cases of LPL/WM also exist.lld:pubmed
pubmed-article:16191510pubmed:languageenglld:pubmed
pubmed-article:16191510pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16191510pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16191510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16191510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16191510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16191510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16191510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16191510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16191510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16191510pubmed:statusMEDLINElld:pubmed
pubmed-article:16191510pubmed:monthSeplld:pubmed
pubmed-article:16191510pubmed:issn0002-9173lld:pubmed
pubmed-article:16191510pubmed:authorpubmed-author:DayJ OJOlld:pubmed
pubmed-article:16191510pubmed:authorpubmed-author:MedeirosL...lld:pubmed
pubmed-article:16191510pubmed:authorpubmed-author:JorgensenJeff...lld:pubmed
pubmed-article:16191510pubmed:authorpubmed-author:Bueso-RamosCa...lld:pubmed
pubmed-article:16191510pubmed:authorpubmed-author:KonoplevSerge...lld:pubmed
pubmed-article:16191510pubmed:issnTypePrintlld:pubmed
pubmed-article:16191510pubmed:volume124lld:pubmed
pubmed-article:16191510pubmed:ownerNLMlld:pubmed
pubmed-article:16191510pubmed:authorsCompleteYlld:pubmed
pubmed-article:16191510pubmed:pagination414-20lld:pubmed
pubmed-article:16191510pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:meshHeadingpubmed-meshheading:16191510...lld:pubmed
pubmed-article:16191510pubmed:year2005lld:pubmed
pubmed-article:16191510pubmed:articleTitleImmunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.lld:pubmed
pubmed-article:16191510pubmed:affiliationDepartment of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.lld:pubmed
pubmed-article:16191510pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16191510lld:pubmed